These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 1875165)

  • 1. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE; Weiss J; Doerfler ME; Elsbach P
    J Exp Med; 1991 Sep; 174(3):649-55. PubMed ID: 1875165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
    Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
    Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
    Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Elsbach P; Weiss J
    Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
    Marra MN; Wilde CG; Griffith JE; Snable JL; Scott RW
    J Immunol; 1990 Jan; 144(2):662-6. PubMed ID: 2295804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional organization of the human neutrophil 60 kDa bactericidal/permeability-increasing protein.
    Ooi CE; Weiss J; Elsbach P
    Agents Actions; 1991 Sep; 34(1-2):274-7. PubMed ID: 1793043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin.
    Elsbach P
    Ciba Found Symp; 1994; 186():176-87; discussion 187-9. PubMed ID: 7768151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J
    J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a potent novel endotoxin antagonist.
    Uknis ME; Wasiluk KR; Acton RD; Klaerner HG; Dahlberg PS; Ilyina EE; Haseman JR; Gray BH; Mayo KH; Dunn DL
    Surgery; 1997 Aug; 122(2):380-5. PubMed ID: 9288144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein.
    Ooi CE; Weiss J; Elsbach P; Frangione B; Mannion B
    J Biol Chem; 1987 Nov; 262(31):14891-4. PubMed ID: 3667613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide.
    Gazzano-Santoro H; Parent JB; Grinna L; Horwitz A; Parsons T; Theofan G; Elsbach P; Weiss J; Conlon PJ
    Infect Immun; 1992 Nov; 60(11):4754-61. PubMed ID: 1398985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS.
    Mészáros K; Parent JB; Gazzano-Santoro H; Little R; Horwitz A; Parsons T; Theofan G; Grinna L; Weickmann J; Elsbach P
    J Leukoc Biol; 1993 Dec; 54(6):558-63. PubMed ID: 8245707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein.
    Kohn FR; Kung AH
    Infect Immun; 1995 Jan; 63(1):333-9. PubMed ID: 7806373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
    Levy O; Sisson RB; Kenyon J; Eichenwald E; Macone AB; Goldmann D
    Infect Immun; 2000 Sep; 68(9):5120-5. PubMed ID: 10948134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
    Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.
    Gazzano-Santoro H; Mészáros K; Birr C; Carroll SF; Theofan G; Horwitz AH; Lim E; Aberle S; Kasler H; Parent JB
    Infect Immun; 1994 Apr; 62(4):1185-91. PubMed ID: 8132325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function.
    Capodici C; Weiss J
    J Immunol; 1996 Jun; 156(12):4789-96. PubMed ID: 8648126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin].
    Zhou H
    Zhonghua Shao Shang Za Zhi; 2001 Apr; 17(2):102-4. PubMed ID: 11876922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.